Terms: = Breast cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31
11 results:
1. Inhibitory Effect of Dextran Derivatives on Multidrug Resistance-Related Efflux Transporters in Vitro.
Morimoto K; Ishii M; Sugimoto Y; Ogihara T; Tomita M
Biol Pharm Bull; 2022; 45(8):1036-1042. PubMed ID: 35908887
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Hub Genes Using Co-Expression Network Analysis in breast cancer as a Tool to Predict Different Stages.
Fu Y; Zhou QZ; Zhang XL; Wang ZZ; Wang P
Med Sci Monit; 2019 Nov; 25():8873-8890. PubMed ID: 31758680
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer.
Wang Q; Ye T; Chen HL; Zhang XG; Zhang LZ
Eur Rev Med Pharmacol Sci; 2016; 20(1):75-81. PubMed ID: 26813456
[TBL] [Abstract] [Full Text] [Related]
4. Diastolic Dysfunction Occurs Early in HER2-Positive breast cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.
Cao L; Cai G; Chang C; Miao AY; Yu XL; Yang ZZ; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
Oncologist; 2015 Jun; 20(6):605-14. PubMed ID: 25933931
[TBL] [Abstract] [Full Text] [Related]
5. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy.
Cao L; Hu WG; Kirova YM; Yang ZZ; Cai G; Yu XL; Ma JL; Guo XM; Shao ZM; Chen JY
Cancer Radiother; 2014 Mar; 18(2):119-24. PubMed ID: 24642505
[TBL] [Abstract] [Full Text] [Related]
6. [The role of whole brain radiotherapy with hippocampal-sparing].
Truc G; Martin É; Mirjolet C; Chamois J; Petitfils A; Créhange G
Cancer Radiother; 2013 Oct; 17(5-6):419-23. PubMed ID: 24011597
[TBL] [Abstract] [Full Text] [Related]
7. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
[TBL] [Abstract] [Full Text] [Related]
8. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
Martínez-Zaguilán R; Raghunand N; Lynch RM; Bellamy W; Martinez GM; Rojas B; Smith D; Dalton WS; Gillies RJ
Biochem Pharmacol; 1999 May; 57(9):1037-46. PubMed ID: 10796074
[TBL] [Abstract] [Full Text] [Related]
9. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene.
Peterson G; Barnes S
Biochem Biophys Res Commun; 1991 Aug; 179(1):661-7. PubMed ID: 1883387
[TBL] [Abstract] [Full Text] [Related]
10. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
[TBL] [Abstract] [Full Text] [Related]
11. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract] [Full Text] [Related]
